Behera B C, Bhunya S P
P.G. Department of Zoology, Utkal University, Bhubaneswar, Orissa, India.
Mutat Res. 1989 Jul;223(3):287-93. doi: 10.1016/0165-1218(89)90121-3.
The genotoxic potential of asataf (acephate) was evaluated by a battery of in vivo tests: bone marrow chromosome aberrations, micronucleus, sperm-shape abnormality and dominant lethal tests in mice. A significant enhancement in the percentage of chromosome aberrations was noticed in 3 doses, 3 routes and 3 h after asataf treatment of groups of mice as well as in chronic (sub-acute) treatment. A significant difference in the occurrence of micronuclei was found only at the highest dose whereas all the results of the sperm-shape abnormality test were highly significant. In the dominant lethal mutagenicity assay only the result (dead implants) of a single week (3rd) with the higher dose differed significantly from control. On the basis of the present in vivo results in mouse test systems asataf may be considered to be a potential mutagen.
小鼠骨髓染色体畸变试验、微核试验、精子形态异常试验和显性致死试验。在对小鼠组进行乙酰甲胺磷处理后的3种剂量、3种途径和3小时以及慢性(亚急性)处理中,均发现染色体畸变百分比显著增加。仅在最高剂量下微核发生率存在显著差异,而精子形态异常试验的所有结果均具有高度显著性。在显性致死诱变试验中,仅高剂量组单一周(第3周)的结果(植入物死亡)与对照组有显著差异。根据目前在小鼠试验系统中的体内结果,乙酰甲胺磷可被认为是一种潜在的诱变剂。